Value
9.9/10data confidence 20%| Component | Sub-score |
|---|---|
| P/E | 9.9 |
- ▸Attractively valued
BME · Why this verdict
Why Blackrock Health Sciences Trust (BME) is rated HOLD
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictHOLD
Overall score5.9/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
BlackRock Health Sciences Trust is an attractively valued fund with a 53% margin of safety, strong margins and a 7.0% dividend, in a breakout near its 52-week high, though revenue is declining and there is no analyst coverage.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The trust is attractively valued, with a margin of safety of 53% and a valuation score of 9.9/10. Bull case | Margin of safety stays above 40% over the next 12 months. | →Stable |
| CounterValuation confidence is only 0.2 because few inputs are available, so the margin of safety may be unreliable. | ||
The stock is in a breakout, with a golden cross, price above all moving averages, RSI of 68 and bullish MACD. Chart pattern detection | Price holds above its 200-day average and momentum stays above 5.5. | →Stable |
| CounterOn-balance volume is falling (distribution), and the price is 2.8% from its 52-week high, so a breakout may fail. | ||
The trust pays a 7.0% dividend with a safety score of 8.0/10. Catalyst breakdown | Dividend safety score stays above 6/10 and the 7.0% yield is maintained. | →Stable |
| CounterDividend confidence is only 0.5 and a distribution funded by capital gains rather than income can be cut when markets fall. | ||
Revenue is declining 4% and growth ranks near the bottom of peers, which limits upside. Growth breakdown | Revenue decline narrows to better than -2% YoY within four quarters. | →Stable |
| CounterFor a fund-type vehicle, revenue decline may track portfolio income timing rather than business weakness. | ||
The $51.88 target is a default 15% placeholder because no analyst target exists, so the stated upside is not independently supported. Tp method | Price moves toward $51.88 only if the breakout holds over 12 months. | →Stable |
| CounterTechnical strength with a 9.6/10 52-week position could carry the price past the placeholder target. | ||
The trust is attractively valued, with a margin of safety of 53% and a valuation score of 9.9/10.
→StableBull case
- Expectation
- Margin of safety stays above 40% over the next 12 months.
CounterValuation confidence is only 0.2 because few inputs are available, so the margin of safety may be unreliable.
The stock is in a breakout, with a golden cross, price above all moving averages, RSI of 68 and bullish MACD.
→StableChart pattern detection
- Expectation
- Price holds above its 200-day average and momentum stays above 5.5.
CounterOn-balance volume is falling (distribution), and the price is 2.8% from its 52-week high, so a breakout may fail.
The trust pays a 7.0% dividend with a safety score of 8.0/10.
→StableCatalyst breakdown
- Expectation
- Dividend safety score stays above 6/10 and the 7.0% yield is maintained.
CounterDividend confidence is only 0.5 and a distribution funded by capital gains rather than income can be cut when markets fall.
Revenue is declining 4% and growth ranks near the bottom of peers, which limits upside.
→StableGrowth breakdown
- Expectation
- Revenue decline narrows to better than -2% YoY within four quarters.
CounterFor a fund-type vehicle, revenue decline may track portfolio income timing rather than business weakness.
The $51.88 target is a default 15% placeholder because no analyst target exists, so the stated upside is not independently supported.
→StableTp method
- Expectation
- Price moves toward $51.88 only if the breakout holds over 12 months.
CounterTechnical strength with a 9.6/10 52-week position could carry the price past the placeholder target.
Per-dimension breakdown
Quality
6.0/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 6.4 |
| ROA | 0.1 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Current ratio | 3.3 |
| Moat | 6.6 |
| Piotroski F | 5.6 |
Growth
1.6/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 1.6 |
- ▸Declining revenue: -4%
Momentum
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.3 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 2.9 |
- ▸Overbought (RSI 74)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.4/10data confidence 67%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.8 |
| Analyst rating | 5.0 |
Insider
3.9/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 3.8 |
| notable moves | 3.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
6.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 3.6 |
| quality rank | 8.8 |
| growth rank | 2.9 |
- ▸Best-in-class margins
- ▸Conservative debt levels
Technical
3.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.2 |
| support resistance | 0.1 |
| 52w position | 10.0 |
Risk (lower is worse)
8.8/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 9.9 |
| days to cover | 10.0 |
| volatility | 8.3 |
| beta | 9.4 |
| debt equity | 10.0 |
| news risk | 5.5 |
Catalyst
6.5/10data confidence 50%| Component | Sub-score |
|---|---|
| dividend safety | 7.0 |
| news activity | 6.0 |
- ▸Dividend: 6.8%
How the verdict was assembled
Engine trigger
Maintain position. Not compelling to add more.
Engine technical detail
verdict_path:
L4:PATH_F_HOLDPassed (6)
- MOMENTUM:7.2>=5.5
- INSIDER:OK
- 8K:CLEAN
- EARNINGS_PROXIMITY:NO_DATE
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (1)
- ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
8.6%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeInst Constrain — Small cap ($0.6B) below institutional reach
SuitabilityAggressive — MCap $0.6B<$5B
Investment implication
None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:7.2>=5.5. Top dim: Value at 9.9; weakest: Growth at 1.6. No conviction either direction.
The strongest dimensions are Value at 9.9, Risk (lower is worse) at 8.8, and Momentum at 7.2; the weakest are Growth at 1.6, Technical at 3.8, and Insider at 3.9. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Margin Of Safety Valuation
Trip ifMargin of safety falls below 25% from the current 53%.
- P2Breakout Above All Averages
Trip ifMomentum score falls below 4.5 from the current 5.6.
- P3High Dividend With Safety
Trip ifDividend safety score falls below 5.0 from the current 8.0.
- P4Declining Revenue Weak Growth
Trip ifRevenue declines more than 10% YoY from the current -4%.
- P5Placeholder Upside Target
Trip ifPrice rises above $51.88 from the current $45.11.